Dr Shibal Bhartiya- Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya — Glaucoma Specialist in Gurgaon

Glaucoma surgery

Dr. Shibal Bhartiya: Expert Glaucoma Specialist & Clinician-Scientist

Dr. Shibal Bhartiya is a globally recognized authority in Glaucoma and Neuro-Ophthalmology, currently serving as the Clinical Director at Marengo Asia Hospitals, Gurgaon. She is also a Research Collaborator with Mayo Clinic, Jacksonville, USA. Former Senior Scientific Research Fellow (Glaucoma)  University of Geneva, Switzerland & Former Senior Research Associate (Glaucoma + Cornea), AIIMS, New Delhi. 

With over 27 years of experience, she is one of the few specialists in India who seamlessly bridges the gap between high-volume clinical excellence and international medical research.

At a Glance

🎓 Fellowship trained — University of Geneva, Switzerland & AIIMS New Delhi
🔬 Research Collaborator — Mayo Clinic, Jacksonville, USA 
📚 200+ peer-reviewed publications · 20+ edited textbooks on glaucoma
🏆 Best Research Paper Awards — Asia Pacific Academy of Ophthalmology, Asia Pacific Glaucoma Congress, International Society of Glaucoma Surgery
🏥 Clinical Director, Ophthalmology — Marengo Asia Hospitals, Gurgaon

Academic & Research Distinction

As a Research Collaborator with the Mayo Clinic (Jacksonville, USA), Dr. Bhartiya is at the forefront of global innovations in eye care. Her academic journey includes a prestigious Clinical Research Fellowship in Glaucoma from the University of Geneva, Switzerland, and extensive training at AIIMS, New Delhi.

She is a prolific author of 28 medical textbooks and has published over 200 peer-reviewed research papers in international journals. Her leadership in the field is further cemented as the Executive Editor of the Journal of Current Glaucoma Practice and her role on the Associate Advisory Committee of the International Society of Glaucoma Surgery (ISGS).

Her work can be accessed on Pubmed, Google Scholar, ResearchGate and ORCID.

Patient-Centric Excellence

Beyond her academic accolades, Dr. Bhartiya is arguably the most trusted glaucoma specialist in Gurgaon, maintaining a perfect 5.0-star rating across 1,500+ verified patient reviews. She is widely sought after for ethical glaucoma care and second opinions, specializing in:

  • Evidence-Based, Non-Surgical Protocols
  • Complex Glaucoma Management (Medical & Surgical)
  • Neuro-Ophthalmology & Ocular Surface Diseases
  • Minimally Invasive Glaucoma Surgery (MIGS)

Focus Areas: Providing advanced diagnosis, glaucoma treatment, risk stratification, and second opinions for glaucoma and optic nerve disease. Long-term vision protection.

The Ethical Care Philosophy

Dr. Bhartiya is known for her “patient-first” approach, focusing on long-term vision preservation rather than unnecessary surgical intervention. Her practice is built on transparency, humane care, and the same rigorous standards found at the world’s leading eye institutes.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist  in Gurgaon, currently serving as Clinical Director of Ophthalmology at Marengo Asia Hospitals, Sector 56, Gurugram, and as Research Collaborator at Mayo Clinic, Jacksonville, Florida, USA.

Her clinical focus is glaucoma across its full spectrum- from early detection and borderline disease to complex surgery and second opinions for patients who need clarity on a difficult diagnosis. She also sees patients with neuro-ophthalmological conditions and ocular surface disease.

Dr Bhartiya trained at AIIMS New Delhi, completed a Clinical Research Fellowship in Glaucoma at the University of Geneva, Switzerland, and is currently enrolled for a Doctorate en Médecin at the University of Geneva. Over two decades of glaucoma specialty practice, international research collaboration, and editorial leadership in glaucoma have shaped an approach to care that is careful, long-term, and built around protecting vision, and not just treating numbers.

What I Treat

My practice is focused on patients with glaucoma at every stage — from those who have just been told they may be a glaucoma suspect, to those managing advanced disease after failed surgery. I also see a significant number of patients who come for a structured second opinion, from Gurgaon, NCT and all over India, often after an unclear diagnosis or conflicting advice from different doctors.

Conditions I see regularly: — Primary open-angle glaucoma and normal tension glaucoma — Angle closure glaucoma and angle closure suspects — Ocular hypertension and glaucoma suspects — Secondary glaucomas: steroid-induced, post-uveitic, post-traumatic, after retinal surgery or corneal transplant  Neovascular and complex refractory glaucoma

 Neuro-ophthalmological conditions: optic neuropathy, unexplained visual field loss, optic neuritis, papilledema — Ocular surface disease and dry eye in the context of glaucoma treatment

If you are unsure whether your situation fits, the contact page has details for reaching my coordinator directly. You can also reach me through the Marengo Asia Hospitals appointment page here

Training and Qualifications

Fellowship Training

Clinical Research Fellowship in Glaucoma, Clinique d’Ophtalmologie, Department of Clinical Neurosciences, Hôpitaux Universitaires de Genève, University of Geneva, Switzerland (2010–11).

Also enrolled: Doctorat en Médecin, University of Geneva.

Senior Clinical Research Associate, Cornea and Glaucoma Services, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi (2007–10).

MS Ophthalmology, Maulana Azad Medical College, New Delhi (2007–10).

Current Positions

Clinical Director, Ophthalmology, Marengo Asia Hospitals, Gurugram (July 2024 to date) Program

Director, Community Outreach & Wellness,  Marengo Asia Hospitals, Gurugram and Faridabad

Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)

Research Collaborator, Mayo Clinic, Jacksonville, Florida, USA (September 2024 to date)

Academic and Editorial Leadership

Dr Bhartiya holds editorial positions at three international peer-reviewed journals:

 Editor-in-Chief, Clinical and Experimental Vision and Eye Research 

Editor-in-Chief, Ocular Research Journal

Executive Editor, Journal of Current Glaucoma Practice

She is a Member of the Associate Advisory Committee, International Society of Glaucoma Surgery, and serves on the Delhi Ophthalmic Society International Advisory Sub-Committee.

She has edited more than 20 textbooks in glaucoma and ophthalmology, and contributed chapters to more than 20 others. Her peer-reviewed research is indexed on PubMed and Google Scholar.

Awards and Recognition

Best Paper, Glaucoma Session — APAO, Hyderabad (Continuous IOP Monitoring in Glaucoma)

Best Paper, Glaucoma Session and Top Nine Most Influential Papers — Asia Pacific Glaucoma Congress, Bali 2012 (Diurnal IOP Fluctuation in Angle Closure)

 Multiple best paper recognitions at International Society for Glaucoma Surgery congresses

Global Outreach and Community Work

Beyond clinical practice, Dr Bhartiya has led glaucoma screening and surgical programmes in underserved communities across three continents.

In Egypt, she led a humanitarian mission to Kom Ombo General Hospital, Aswan, conducting screening for over 5,000 patients including children, and provided both medical and surgical management of advanced glaucomas in North Africa. She has also delivered skill-transfer sessions in advanced glaucoma care for doctors, residents, and optometrists in Aswan.

In Switzerland, she designed and executed hospital-based and community glaucoma screening protocols in Geneva and Troinnex, and led screening of United Nations personnel as part of World Glaucoma Week.

In India, she is an active contributor to the Motiabind Mukti Abhiyan cataract outreach programme, has led eye camps in Sirsa (Haryana), and runs school health initiatives and government employee screening programmes in Gurugram.

She is also the founder of Vision Unlimited, a not-for-profit organisation currently running six learning centres in urban Gurugram, serving over 1,200 children with education, nutrition, and healthcare support.

As part of the Eye on the Future program, Vision Unlimited under the guidance of Dr Bhartiya has screened more than 15000 school children; and 5000 elders from underserved areas for refractive errors, and other ocular morbidities. 

Research

Active clinical research collaborations span glaucoma medication adherence, quality of life, IOP monitoring, community-based screening, and surgical outcomes. Dr Bhartiya collaborates with glaucoma specialists across more than 20 countries.

Current trials include work on 24-hour ambulatory IOP monitoring, selective laser trabeculoplasty as primary therapy, tear film osmolarity in glaucoma patients, and quantitative versus qualitative IOP control, as well as metabolic determinants of glaucoma.

Full publication list: PubMed · Google Scholar · Publications page

Book an Appointment

For appointments at Marengo Asia Hospitals, Sector 56, Gurugram, please contact my coordinator at +91 88826 38735.

If you are seeking a structured glaucoma second opinion, you may also use the second opinion form to submit your reports in advance of your consultation.

As a fellowship-trained glaucoma specialist (from University of Geneva, Switzerland, and AIIMS, New Delhi) in Gurgaon, Dr Shibal Bhartiya works with patients across the full spectrum of glaucoma—from suspects and early disease to advanced and complex cases. Her approach emphasises risk stratification, longitudinal follow-up, and calm decision-making, helping patients avoid late surprises and unnecessary interventions.

Patients often seek her care for early glaucoma diagnosis, second opinions, treatment planning, and long-term glaucoma management (medical, glaucoma lasers and glaucoma surgery including MIGS, trabeculectomy and complex tubes and shunts), especially when clarity is needed in uncertain, complex, or borderline cases.

Academic Qualifications:

  • 2010-11 – Clinical Research Fellowship, Glaucoma, University of Geneva, Switzerland
  • 2007-10 – MS (Ophthalmology), Maulana Azad Medical College, New Delhi, India
    1993-99 – M.B.B.S, Maulana Azad Medical College, New Delhi
  • 2000-03 – Clinical Research Associateship, Cornea and Glaucoma, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Doctorate en Medicin, University of Geneva, Switzerland (Currently enrolled)

Experience details:

  • July 2024 to date- Clinical Director, Ophthalmology (MAH, Gurgaon); Program Director, Community Outreach & Wellness (MAH, Gurgaon and Faridabad)
    Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)
  • Sept 2024 to date– Research collaborator, Mayo Clinic, Jacksonville, USA
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2012-July 2024- Director, Additional Director, Sr. Consultant, Consultant – Ophthalmology, Fortis Memorial Research Institute, India

Additional Role

  • Sept 2024 – till date- Research collaborator, Mayo Clinic, Jacksonville, USA
  • August 2015-October 2015- Consultant, Cantahealth, Healthcare Practice, Eliglobal, Charlotte, North Carolina, USA. (Training and development of AI platforms and interfaces in Ophthalmology)
  • Oct 2015- April 2017- Clinical Director, Medflow, Eye Care Leaders (Eliglobal), Charlotte, North Carolina, USA. (Training and development of AI platforms and CDSS interfaces in Ophthalmology)
  • Sept 2012 to Aug 2015 – Consultant, Glaucoma and Preventive Health Services, Department of Ophthalmology, Fortis Memorial Research Institute, Gurgaon, Haryana
  • Sept 2011 to Aug 2012 – Consultant Glaucoma and In charge of Academics and Research, Eye 7 Group of Hospitals, New Delhi
  • Jul 2010 to Jul 2011 – Senior Scientific- Clinical Research Fellow, Glaucoma Sector, Clinique d’ ophthalmologie, Department of Clinical Neurosciences, Glaucoma Sector, Hopitaux Universitaires de Geneve, Switzerland. (Responsibilities including teaching resident doctors and glaucoma fellows)
  • Mar 2007 to Mar 2010 – Senior Research Associate, Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, AIIMS, New Delhi. (Responsibilities including teaching resident doctors)
  • Sept 2003 to Sept 2006 – Senior Registrar, University College of Medical Sciences, and associated Guru Teg Bahadur Hospital, New Delhi. (Responsibilities including teaching resident doctors)

Languages known:

English, Hindi, Urdu, French

Academic, Organisational and Leadership positions:

  • 2024 – Present- Editor in Chief, Ocular Research Journal
  • 2017-to date: Founder, Vision Unlimited, Not for Profit Organization for social responsibility https://vision-unlimited.org/
  • 2019-to date – Editor in Chief –Clinical and Experimental Vision and Eye Research https://www.cleverjournal.org/ https://www.cleverjournal.org/editorial-team/
  • 2016-to date –  Executive Editor – Journal of Current Glaucoma Practice https://www.jocgp.com/journalDetails/JOCGP https://www.jocgp.com/editorialBoard/JOCGP
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2024 to Date- Member, Program Committee, Bal Raksha Bharat, Save the Children, India
  • 2016 to 2021: Executive Editor-DOS Times
  • 2016-till date: Founder Member, Khem, LGBTQ Rights
  • 2009 to 2016 – Managing Editor – Journal of Current Glaucoma Practice
  • 2023 to date- Member, Delhi Ophthalmic Society International advisory sub-committee
  • 2011 – Founding Secretary – Shamms Ed Deen Alcon Glaucoma Fund, University of Geneva, Switzerland
  • 2013 – Member Scientific Committee – World Glaucoma Congress
  • 2012 – Member Scientific Committee – International Society for Glaucoma Surgery
  • 2010 – Member, Organising Committee – International Society for Glaucoma Surgery
  • Apr 2008 to Dec 2009 – Associate Editor – Delhi Journal of Ophthalmology
  • 2008 – Co-Editor – Proceedings of the Strabismic Panorama
  • 2001 to 2003 – Assistant Editor – Indian Journal of Strabismology and Pediatric Ophthalmology
  • 2007 to 2008 – Deputy Editor – Delhi Journal of Ophthalmology
  • Reviewer for several journals worldwide.

Professional Memberships:

  • International Society of Glaucoma Surgery
  • Glaucoma Society of India
  • Strabismological Society of India
  • All India Ophthalmological Society
  • Delhi Ophthalmological Society
  • Haryana Ophthalmological Society
  • Gurugram Ophthalmological Society
  • American Academy of Ophthalmology
  • Association for Research and Vision in Ophthalmology

Community Ophthalmology Programmes:

  • Responsible for design of skill transfer sessions in glaucoma care, and for screening manuals for glaucoma in Africa and the Middle East. Projected collaboration in execution
  • Skill transfer sessions in advanced glaucoma care in Aswan, Egypt for doctors, residents and optometrists
  • Humanitarian mission to Kom Ombo General Hospital, Aswan, Egypt. Screening program for over 5000 patients, including children for glaucoma in Kom Ombo General Hospital, Aswan, Egypt
  • Management, both medical and surgical, of advanced glaucomas in North Africa
  • Screening for glaucoma and designing and execution of protocols and SOPs for hospital based and community outreach programs, Geneva and Troinnex, Switzerland
  • Screening of UN personnel for glaucoma in an outreach exercise as part of World Glaucoma Week in Geneva, Switzerland
  • Actively involved in the Motiabind Mukti Abhiyan, an outreach program for cataract management in India
  • Execution of eye camps in Sirsa, Haryana, as part of a community sponsored initiative
  • School health and eye care initiatives, Gurugram, Haryana
  • Screening programs for police officers and government officials in Gurugram, Haryana
  • Screening programs for community based screening in Pilibhit, UP and Mewat, Haryana

Design of clinical trials:

  • Population based survey of anterior chamber configuration in North African populations
  • Histochemical correlates of chronic glaucoma medication use on trabecular meshwork and ocular surface
  • Persistency, adherence and compliance to glaucoma medications
  • Selective laser trabeculoplasty as primary therapy in an African population: An efficacy and economics perspective
  • Tear film osmolarity studies in patients on glaucoma therapy
  • Comparative evaluation of sclerothalamotomy ab interno combined with phacoemulsification versus phacoemulsification alone in POAG patients
  • Quantitative versus qualitative control of IOP: A risk benefit analysis
  • 24 hour ambulatory IOP monitoring in angle closure glaucoma
  • Effect of increased intraocular pressure on retinal ganglion cells in chick embryos

Awards

  • Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost. Shibal Bhartiya, Aref A, Shaarawy T. APAO, Hyderabad, India. Best Paper, Glaucoma session
  • Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. Asia Pacific Glaucoma Congress 2012, Bali, Indonesia. Best paper glaucoma session, Top nine most influential papers of the congress
  • Harry Potter and the Ophthalmologists Nemesis: Shibal B., S Khokhar, IV International Congress of Glaucoma Surgery, April 2009, Geneva. Best Poster
  • Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. S.Bhartiya, Jayaprakash V, T Dada, A Panda. DOS Annual Conference, March 2009.Best free paper, glaucoma session.
  • Evaluation of levo-dopa as a therapeutic adjunct to conventional occlusion in amblyopia; Kamlesh, Dadeya S, Shibal F. DOS Midcon, 2001 .Best free paper, squint session.
  • Asia ARVO Young Scientists Travel Grant for the year 2008
  • CSIR Young Scientists Travel Grant for the year 2003,2009
  • World Glaucoma Association Young Scientists Travel Grant for the year 2009, 2013Ju

CV

Published Articles

Glaucoma FAQs: Expert Answers from a Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care.

These answers are drawn from real questions patients bring to the clinic: at first diagnosis, during follow-up, and when seeking a structured glaucoma second opinion in Gurgaon. If you do not find what you are looking for here, reach out directly.


What is glaucoma? Can it be prevented?

Glaucoma is a group of eye diseases that damage the optic nerve, causing progressive and irreversible vision loss. It is the second most common cause of blindness worldwide. Most people have no symptoms until significant damage has already occurred.

Glaucoma cannot be prevented. However, early detection and consistent treatment can slow progression and protect functional vision for life. The key is finding it before the damage is done. This is why regular screening matters, especially if you carry a family history of glaucoma.

Glaucoma tests are painless. A standard screening includes a vision check and eye pressure measurement. Depending on your risk profile, your doctor may also recommend a visual field test, an OCT scan to measure nerve fibre thickness, and a gonioscopy to examine the drainage angle of the eye. Learn more about glaucoma diagnosis in Gurgaon.


What puts me at risk for glaucoma?

Anyone above 40 should have an annual eye check. The following risk factors increase urgency significantly:

  • Family history of glaucoma — the single strongest risk factor
  • History of eye injury or trauma
  • Long-term use of steroid medications, including eye drops, inhalers, or oral steroids
  • Diabetes or thyroid disease
  • History of migraines or vasospastic disorders such as Raynaud’s disease
  • Sleep apnea
  • Alzheimer’s disease
  • High myopia (shortsightedness) or high hypermetropia (longsightedness)
  • Symptoms such as frequent prescription changes, coloured haloes around lights, headaches with nausea, or sudden blurring of vision

Vision lost to glaucoma cannot be recovered. Once nerve fibres are gone, they do not grow back. Regular eye exams are not optional if you carry these risk factors, they are what stand between you and preventable blindness. Understand glaucoma risk in depth here.


What happens during a glaucoma check-up?

Bring all previous eye records, your current glasses, any eye drops you are using, and your full medical file: not just eye records. Conditions such as diabetes, blood pressure, and thyroid disease all have relevance to glaucoma management.

Before you see the doctor, an optometrist will check your vision and eye pressure. Your doctor will then examine your optic nerve and retina. Additional tests may include a visual field test, an OCT scan, pachymetry (corneal thickness), a water drinking test, and a dilated eye exam.

After the tests, your doctor will explain findings clearly and outline a plan. Do not drive yourself to the appointment: your eyes may be dilated, which blurs vision for approximately three hours. Bring sunglasses.


I have glaucoma. Will I go blind?

In most cases, no- provided care is consistent. With proper medical care, glaucoma blindness is avoidable. Patients who use their eye drops as prescribed, attend follow-up appointments, and respond to treatment adjustments generally retain their vision for life.

The variables that matter most are: how early the disease was detected, how well eye pressure is controlled, and how reliably treatment is continued. Glaucoma is not a condition where you treat it and forget it. It requires steady, long-term management.

If glaucoma has advanced significantly, surgery may be recommended to slow further progression. In cases with severe visual field constriction, low vision aids can support daily mobility and independence.

The most important thing you can do today is ask your doctor honest questions about your disease stage and what your realistic prognosis looks like with good adherence. Lifestyle changes that support glaucoma management are discussed here.


How often should I see my doctor after a glaucoma diagnosis?

Frequency depends on disease severity, eye pressure control, and how stable your condition is. Here is a general framework:

  • Glaucoma suspect: Annual review with full testing, more often if your doctor recommends it
  • Early glaucoma, well-controlled: Every 6 to 12 months
  • Moderate or advanced glaucoma, or poorly controlled pressure: Every 3 to 6 months
  • After surgery: Intensive early follow-up, then gradual spacing as the eye stabilises

Even after surgery, eye drops may still be needed. Even if pressure is well-controlled, regular visits remain essential. Glaucoma can change silently. Gaps in follow-up are where damage accumulates.

If you are unsure whether your current follow-up schedule is appropriate, a structured glaucoma second opinion can provide clarity on both disease status and the right monitoring plan. Read more about glaucoma treatment planning here.


How can I support a family member or partner who has glaucoma?

A glaucoma diagnosis can be frightening. The word carries the weight of possible blindness, even when the actual prognosis with treatment is good. Your most important role early on is reassurance: with consistent care, blindness is not the inevitable outcome.

Practically, you can help by:

  • Reminding them to use their eye drops at the same time each day
  • Driving them to clinic appointments, particularly when eyes are dilated
  • Helping them track and attend follow-up visits
  • Learning enough about the condition to ask informed questions during consultations
  • Help them manage anxiety and depression through support, and medical help when required

If your family member has significant visual impairment, discuss visual rehabilitation options and low vision aids with their doctor. Support groups and rehabilitation services exist specifically for this. You do not have to navigate it alone. Read more about glaucoma and quality of life here.


What does vision loss from glaucoma actually feel like?

This is one of the most important, and most misunderstood, aspects of glaucoma. Most patients feel nothing. Even significant visual field loss often goes unnoticed because the brain compensates automatically by filling in missing areas. This is why patients sometimes underestimate their own disease severity.

The Glaucoma SIM App, developed in partnership with MSD Pharmaceuticals, the International Glaucoma Association, and Moorfields Eye Hospital, allows you to simulate what progressive glaucoma field loss looks like over time. It is available on the Apple App Store (search: Glaucoma SIM). Verify availability for your region before downloading.

Understanding what is happening to your vision, even when you cannot feel it, is one of the strongest motivators for staying consistent with treatment.


How do I choose a glaucoma doctor? When should I seek a second opinion?

A good glaucoma specialist listens carefully, explains your diagnosis in plain language, and makes treatment decisions transparently. Credentials matter: look for fellowship training in glaucoma, peer-reviewed publications, and clinical experience with complex cases including surgery.

A second opinion is not a sign of distrust. It is a standard part of managing a serious, lifelong condition. Seek one proactively if:

  • You have been recently diagnosed and want to confirm the findings
  • Your disease appears to be progressing despite treatment
  • Surgery has been recommended and you want to understand all your options
  • You are uncertain about your current treatment plan or follow-up schedule
  • You have seen multiple doctors and received different advice

Dr Shibal Bhartiya offers structured glaucoma second opinions in Gurgaon, as well as online consultations for patients elsewhere in India. She works in partnership with your local doctor to guide care over time- you do not need to change your primary treating physician. Submit a second opinion request here.


What are reliable resources for learning more about glaucoma?

Use these trusted sources for current, evidence-based information:


Book a Glaucoma Evaluation or Second Opinion

Not sure about your diagnosis? Concerned about progression? Want clarity before agreeing to surgery? Dr Shibal Bhartiya brings over 25 years of fellowship-trained glaucoma expertise, Mayo Clinic research collaboration, and 90+ peer-reviewed publications to every patient evaluation.

Consultations are available in person at Marengo Asia Hospitals, Sector 56, Gurgaon, and online for patients outside the city. Book an appointment here or call +91 88826 38735. You can also submit a second opinion request online.

For patients who live elsewhere, Dr Bhartiya is happy to work in partnership with your local eye doctor to guide and support your care over time.


Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.